葛兰素史克
40.91
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 葛兰素史克
葛兰素史克公司（GlaxoSmithKline Plc）是一家全球性医疗保健公司，从事药物，疫苗和消费者保健产品的研究，开发和生产。 它通过以下四个领域运作：制药，制药研发，疫苗和消费者保健。 药品部门研究，开发并提供可用于治疗各种严重和慢性疾病的药物。 疫苗部门生产儿科和成人疫苗，以预防一系列传染病，包括甲型和乙型肝炎，白喉，破伤风和百日咳，麻疹，腮腺炎和风疹，脊髓灰质炎，伤寒，流感和细菌性脑膜炎。 消费者保健事业部基于科学创新销售一系列消费者保健产品。 该公司成立于1715年，总部位于英国布伦特福德。
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.